Jennifer I. Hare

Development of a liposomal nanoparticle formulation of 5-Fluorouracil for parenteral administration: Formulation design, pharmacokinetics and efficacy

A.M. Thomas, Anita I. Kapanen, Jennifer I. Hare et al. · Journal of Controlled Release · 2010 · 75 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Tumour regression and improved gastrointestinal tolerability from controlled release of SN-38 from novel polyoxazoline-modified dendrimers

R. England, Jennifer I. Hare, Jennifer Barnes et al. · Journal of Controlled Release · 2016 · 49 citations · Full text

Pharmacy, Oncology, Pharmacology +15

Treatment of Colorectal Cancer Using a Combination of Liposomal Irinotecan (Irinophore C™) and 5-Fluorouracil

Jennifer I. Hare, Robert W. Neijzen, Malathi Anantha et al. · PLoS ONE · 2013 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer

Jennifer I. Hare, Elaine H. Moase, Theresa M. Allen · Journal of drug targeting · 2012 · 25 citations

Pharmacy, Oncology, Pharmacology +17

Evaluation of dynamic contrast-enhanced MRI biomarkers for stratified cancer medicine: How do permeability and perfusion vary between human tumours?

Ross A. Little, Hervé Barjat, Jennifer I. Hare et al. · Magnetic Resonance Imaging · 2017 · 23 citations · Full text

Medicine, Oncology, Radiology +17